182 related articles for article (PubMed ID: 7150874)
1. The effect of chlorpromazine, metyrapone, imipramine and SKF 525-A on the hepatic first pass elimination of propranolol in the pithed rat.
Barber HE; Kitteringham NR; Petrie JC
Br J Pharmacol; 1982 Dec; 77(4):667-77. PubMed ID: 7150874
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of soybean lipoxygenase by SKF 525-A and metyrapone.
Pretus HA; Ignarro LJ; Ensley HE; Feigen LP
Prostaglandins; 1985 Oct; 30(4):591-8. PubMed ID: 3936118
[TBL] [Abstract][Full Text] [Related]
3. Effect of inflammation and proadifen on the disposition of antipyrine, lignocaine and propranolol in rat isolated perfused liver.
Chindavijak B; Belpaire FM; Bogaert MG
J Pharm Pharmacol; 1987 Dec; 39(12):997-1002. PubMed ID: 2894448
[TBL] [Abstract][Full Text] [Related]
4. Effect of inflammation on the metabolism of antipyrine, lidocaine and propranolol in isolated rat hepatocytes.
Chindavijak B; Belpaire FM; Bogaert MG
Pharmacology; 1988; 36(4):279-82. PubMed ID: 3380881
[TBL] [Abstract][Full Text] [Related]
5. Effects of chlorpromazine, imipramine and baclofen on the spinal polysynaptic reflex in acute, chronic and 6-hydroxydopamine-treated spinal rats.
Ito T; Furukawa K; Karasawa T; Kadokawa T; Shimizu M
Jpn J Pharmacol; 1982 Dec; 32(6):1125-33. PubMed ID: 6819374
[TBL] [Abstract][Full Text] [Related]
6. The possible role of cytochrome P-450 in the liver "first pass elimination" of a beta-receptor blocking drug.
Grundin R; Moldéus P; Orrenius S; Borg KO; Skånberg I; von Bahr C
Acta Pharmacol Toxicol (Copenh); 1974 Sep; 35(3):242-60. PubMed ID: 4479306
[No Abstract] [Full Text] [Related]
7. Uptake of propranolol by the lung and its displacement by other drugs: involvement of the alveolar macrophage.
Kornhauser DM; Vestal RE; Shand DG
Pharmacology; 1980; 20(5):275-83. PubMed ID: 7393995
[TBL] [Abstract][Full Text] [Related]
8. Drug metabolism in isolated rat liver cells.
Grudin R; Moldèus P; Vadi H; Orrenius S
Adv Exp Med Biol; 1975; 58(00):251-69. PubMed ID: 239539
[No Abstract] [Full Text] [Related]
9. Effects of chlorpromazine on the disposition and beta-adrenergic blocking activity of propranolol in the dog.
Bai SA; Abramson FP
J Pharmacokinet Biopharm; 1984 Jun; 12(3):333-49. PubMed ID: 6502474
[TBL] [Abstract][Full Text] [Related]
10. Effect of metyrapone on tryptophan binding to rat hepatic nuclei.
Verney E; Sidransky H
Metabolism; 1994 Jan; 43(1):79-84. PubMed ID: 7507198
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of prostaglandin E2 catabolism and potentiation of hepatic prostaglandin E2 action in rat hepatocytes by inhibitors of oxidative metabolism.
Brass EP; Beyerinck RA; Garrity MJ
Biochem Pharmacol; 1988 Apr; 37(7):1343-9. PubMed ID: 3162676
[TBL] [Abstract][Full Text] [Related]
12. Glutathione (GSH) content in livers from control and carbon tetrachloride poisoned rats treated with the calmodulin inhibitors thioridazine, imipramine or chlorpromazine.
Villarruel MC; de Ferreyra EC; Bernacchi AS; Castro JA
Res Commun Chem Pathol Pharmacol; 1988 Jun; 60(3):397-400. PubMed ID: 3175337
[TBL] [Abstract][Full Text] [Related]
13. Reduction of serotonin-2 receptors in rat cerebral cortex after subchronic administration of imipramine, chlorpromazine, and the combination thereof.
Mikuni M; Meltzer HY
Life Sci; 1984 Jan; 34(1):87-92. PubMed ID: 6694512
[TBL] [Abstract][Full Text] [Related]
14. Detection of covalently bound halothane metabolites in the hypoxic rat model for halothane hepatotoxicity.
Gandolfi AJ; Sipes IG; Brown BR
Fundam Appl Toxicol; 1981; 1(3):255-9. PubMed ID: 7184790
[TBL] [Abstract][Full Text] [Related]
15. Some chemical and biochemical aspects of liver microsomal metabolism of tamoxifen.
Ruenitz PC; Bagley JR; Pape CW
Drug Metab Dispos; 1984; 12(4):478-83. PubMed ID: 6148216
[TBL] [Abstract][Full Text] [Related]
16. In vivo study of propranolol and metabolite(s) disposition in rat liver.
Ong H; du Souich P; Marchand C
Drug Metab Dispos; 1981; 9(6):529-34. PubMed ID: 6120811
[TBL] [Abstract][Full Text] [Related]
17. Effect of subchronic treatment with imipramine, chlorpromazine and the combination on 3H-imipramine binding in rat blood platelets and frontal cortex.
Arora RC; Meltzer HY
Life Sci; 1986 Dec; 39(24):2289-96. PubMed ID: 3796194
[TBL] [Abstract][Full Text] [Related]
18. Dose-dependent presystemic elimination of propranolol due to hepatic first-pass metabolism in rats.
Iwamoto K; Watanabe J
J Pharm Pharmacol; 1985 Nov; 37(11):826-8. PubMed ID: 2867168
[TBL] [Abstract][Full Text] [Related]
19. Influence of proadifen, an inhibitor of the metabolism of drugs, on the action of imipramine and desipramine in rats.
Maj J; Daniel W; Rogóz Z; Skuza G; Sowińska H
Pol J Pharmacol Pharm; 1981; 33(6):559-67. PubMed ID: 7347808
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of antipyrine metabolite formation in rats in vivo.
Rhodes JC; Hall ST; Houston JB
Xenobiotica; 1984 Sep; 14(9):677-86. PubMed ID: 6516440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
